Table 1 Mapping study objectives to education and implementation outcomes
Study Questions | Moore et al.’s (26) framework Level | Implementation outcome |
|---|---|---|
1) Who were the participants in the program? Sub-questions: Were family physicians well-represented? Were prescribers from rural and remote communities well-represented? What proportion of participations had involvement with the medical regulator with respect to controlled substance prescribing? | Participation (LEVEL 1) | Reach |
2) What was the completion rate of the program? Sub-questions: Which participants were more or less likely to complete the program? | Participation (LEVEL 1) | Dose |
3) Did participants note any significant bias in the delivery of the program? | Satisfaction (LEVEL 2) | Fidelity |
4) Was adequate time provided for active learning? Sub-questions: How did ratings of active learning change with respect to cohort size? | Satisfaction (LEVEL 2) | Fidelity |
5) Was the program relevant to clinical practice? Sub-questions: How did ratings of relevance to practice change with respect to cohort size? | Satisfaction (LEVEL 2) | Participant responsiveness |